Researchers identify critical molecular link between inflammation and diabetes

September 12, 2017
insulin
High-resolution model of six insulin molecules assembled in a hexamer. Credit: Isaac Yonemoto/Wikipedia

A new study by researchers at the University of Maryland School of Medicine (UM SOM) has uncovered how inflammation contributes to a key feature of diabetes, the body's inability to metabolize glucose, a condition known as insulin resistance.

More than 30 million Americans suffer from . It is the 7th leading cause of death in the United States. Nearly 80,000 people died directly from the disease, while for another quarter million, it was an underlying or contributing cause of death. The total cost of the disease in the US comes to nearly $250 billion. Nearly all of these cases are type 2 diabetes, which appears in adulthood. Type 1 appears in childhood, and is caused by the body's immune system attacking the cells that make insulin.

Surprisingly, the underlying molecular mechanism for and type 2 diabetes remains mysterious. Diabetes occurs when the body cannot metabolize properly. Normally, the breaks down glucose. But in some people this process becomes increasingly inefficient, a phenomenon known as insulin resistance. Until now, researchers had not understood how insulin resistance turns into full-blown diabetes, in which the body is unable to metabolize sugar properly.

The findings were published recently in the journal Journal of Biological Chemistry. The study is the first to identify a new molecular link between inflammation and the disease.

"Until now, we didn't really understand how insulin resistance occurred," said Xiao-Jian Sun, an assistant professor in the Department of Medicine at UM SOM. "Our study has done something new: it has identified a new molecule involved in the development of insulin resistance."

Dr. Sun's previous research began by focusing on two molecules, Insulin Receptor Substrate-1 and Insulin Receptor Substrate-2, known as IRS-1 and IRS-2. They are key signaling molecules that allow insulin to do its work. In the body, insulin has many jobs: it synthesizes fat, it promotes muscle growth and it breaks down glucose. This is why, in diabetes, patients have multiple problems: the hormone plays many roles.

Over the years, researchers have noticed that many patients suffer from both type 2 diabetes and . Chronic inflammation is caused by many factors, including aging, obesity, and high sugar consumption. These factors also increase the risk of diabetes.

It appears that a gene called IRAK1 (Interleukin-1 receptor-associated kinase 1) plays a key role in this process. For years, researchers have known that inflammation activates IRAK1. Dr. Sun' team discovered that this enzyme blocks insulin signaling in muscle by blocking IRS-1. This blocks insulin signaling, and as a result, significantly reduces the ability of insulin to metabolize glucose in muscle.

His team then tested mice that had been genetically modified so that they lacked IRAK1. They found that these mice had significantly higher insulin sensitivity in muscle than that of regular mice. "What we suspect is that high IRAK1 activity is bad in humans," Dr. Sun says. "It increases insulin resistance, particularly in muscle. This gives us insight into how to improve insulin resistance in patients with diabetes."

Dr. Sun says that in the future it may be possible to test diabetes patients to see what version of IRAK1 they have. Some people have a more active version of the gene, while others have a less active version. With this test, it may be possible to predict how much resistance might be possible with weight loss or other preventive measures. In addition, in the future he hopes to look for drugs that can inhibit IRAK1 activity.

Explore further: Study reveals protein to target in type 2 diabetes

Related Stories

Study reveals protein to target in type 2 diabetes

September 1, 2016
When the body's cells don't respond normally to insulin—a condition known as insulin resistance—blood glucose levels can increase, resulting in type 2 diabetes. Researchers have long known that insulin resistance is linked ...

Lung disease may increase risk of insulin resistance, diabetes, mouse study suggests

September 30, 2015
Numerous studies have identified obesity and poor diet as risk factors for insulin resistance and diabetes. A new study adds another risk factor to the list: inflammatory lung disease. Published in the American Journal of ...

A dual-functional GLP-1 analogue may improve insulin sensitivity and help fight diabetes

May 11, 2017
According to research published online in The FASEB Journal, scientists have discovered a dual peptide called "PGLP-1" that promotes insulin secretion and inhibits gluconeogenesis (a metabolic process that produces glucose). ...

Research links fatty liver disease to type 2 diabetes

October 18, 2016
Insulin resistance in the liver is a major factor in the development of type 2 diabetes, and it is almost always associated with too much fat in the liver—a condition called non-alcoholic fatty liver disease (NAFLD). The ...

Insulin resistance reversed by removal of protein

November 3, 2016
By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of ...

Improved insulin signaling reduces atherosclerosis in mouse models

May 5, 2016
Patients with diabetes and metabolic syndrome are at increased risk of atherosclerosis and subsequent heart disease. It is not fully understood why atherosclerosis is increased with diabetes, but it has been proposed that ...

Recommended for you

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Time to dial back on diabetes treatment in older patients? Study finds 11 percent are overtreated

September 14, 2017
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and ...

Novel way to present pancreatic proteins increases the sensitivity of type 1 diabetes tests

September 13, 2017
Researchers from the Johns Hopkins University School of Medicine, Stanford University and the University of Florida report the development of a novel antibody detection technology that holds promise for improving the accuracy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.